A Rational Pipeline for Development of Novel Anti-TB Drug Regimens

Principal Investigator: David Russell

Department of Microbiology and Immunology
Sponsor:  The Mueller Health Foundation
Title: A Rational Pipeline for Development of Novel Anti-TB Drug Regimens
Project Amount: $50,000
Project Period: September 2022 to August 2023